Suba Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in New York City, NY and active since 1982.
Suba Pharmaceuticals was established in 1982, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Bashir Suba, Owner at the company’s single location by writing to 2721 Broadway, New York City, New York NY 10025 or by phoning (212) 866-6700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Suba Pharmaceuticals |
| Contact Person: | Bashir Suba, Owner |
| Address: | 2721 Broadway, New York City, New York 10025 |
| Phone Number: | (212) 866-6700 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4461100 |
| Share This Business: |
Suba Pharmaceuticals was started in 1982 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bashir Suba, Owner for inquiries that concern Suba Pharmaceuticals by calling the company number (212) 866-6700, as your correspondence is most welcome. Additionally, the physical location of the single location of Suba Pharmaceuticals can be found at the coordinates 40.799939,-73.9684 as well as the street address 2721 Broadway in New York City, New York 10025.
For its online presence, you may visit Suba Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.